{
    "title": "Alzheimer's drug developed by millennial biotech CEO fails in final stage trial",
    "url": "https://www.dailymail.co.uk/health/article-4922330/Setback-Alzheimer-s-drug-fails-final-stage-trial.html",
    "date": "2017-09-26",
    "keywords": [
        "drug",
        "failure",
        "year",
        "intepirdine",
        "dementia",
        "latestage",
        "developer",
        "axovant",
        "potential",
        "treatment",
        "trial",
        "disease",
        "companys",
        "percent",
        "receptor",
        "study",
        "placebo",
        "share",
        "slew",
        "skorney",
        "protein",
        "company",
        "alzheimersa",
        "biotech",
        "ceo",
        "ramaswamy",
        "setback",
        "diseasethe",
        "record",
        "low",
        "morning",
        "trading",
        "class",
        "antagonist",
        "neurotransmitter",
        "cognitionthe",
        "form",
        "statesin",
        "february",
        "lundbeck",
        "surge",
        "lung",
        "spike",
        "article",
        "nail",
        "coffin",
        "mechanism",
        "analyst",
        "client",
        "death",
        "blow",
        "hypothesis",
        "path",
        "cause",
        "triala",
        "biogen",
        "inc",
        "promis",
        "genentech",
        "blood",
        "therapy",
        "trialsaxovant",
        "conference",
        "call",
        "focus",
        "gait",
        "balance",
        "dementiadata",
        "midstage",
        "yearend",
        "population",
        "life",
        "expectancy",
        "researchersintepirdine",
        "improvement",
        "ability",
        "difference",
        "living",
        "background",
        "therapythe",
        "value"
    ],
    "category": [
        "health"
    ]
}